C
CIN Terminal
Cannabis Investor News
A CanIDeal Company
All Insights
J
HoldCIN Rating 58/100How is this calculated?

Tilray's F26 math, MSO earnings lens and a volatile tape

Tilray’s fiscal 2026 results and guidance reframe earnings expectations across U.S. MSOs and ancillaries; watch adjusted-EBITDA-to-FCF conversion and event-driven volatility like IM Cannabis’s 143.1% spike.

Key takeaways
    Share X LinkedIn Email
    Found this useful? Share it X LinkedIn

    More like this, straight to your inbox

    One new CIN Insight + the week's top three signals from the live terminal. Free, weekly.